Cisplatin, current status and new developments

LDR 01293nam a22003251i 4500
001 000741136
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 880718s1980 nyua 10000 eng
010 ‡a80012220
020 ‡a0125650507
035 ‡a(MiU)990007411360106381
035 ‡asdr-miu.990007411360106381
035 ‡a(OCoLC)6087538
035 ‡a(CaOTULAS)159927193
035 ‡a(RLIN)MIUG26368692-B
035 ‡z(MiU)Aleph000741136
040 ‡dMiU
050 0 ‡aRC271.C55 ‡bC57
060 0 ‡aQV290 C579 1979
082 ‡a616.99/4061
245 0 0 ‡aCisplatin, current status and new developments / ‡cedited by Archie W. Prestayko, Stanley T. Crooke, Stephen K. Carter, assisted by Nancy A. Alder.
260 ‡aNew York : ‡bAcademic Press, ‡c1980.
300 ‡axv, 527 p. : ‡bill. ; ‡c24 cm.
500 ‡aPapers presented at a symposium sponsored by the University of Alabama in Birmingham Comprehensive Cancer Center and the Bristol Laboratories, Syracuse, N.Y., and held Sept. 27-28, 1979, in Atlanta, Ga.
538 ‡aMode of access: Internet.
650 0 ‡aCancer ‡xChemotherapy ‡xCongresses.
650 0 ‡aCisplatin ‡xCongresses.
700 1 ‡aCarter, Stephen K., ‡d1937-
700 1 ‡aCrooke, Stanley T.
700 1 ‡aPrestayko, Archie W.
710 2 ‡aBristol Laboratories.
710 2 ‡aUniversity of Alabama in Birmingham. ‡bComprehensive Cancer Center.
CID ‡a000741136
DAT 0 ‡a19911018000000.0 ‡b20210817000000.0
DAT 1 ‡a20210927060711.0 ‡b2023-12-24T18:30:55Z
DAT 2 ‡a2023-12-24T18:30:02Z
CAT ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ‡aBK
HOL ‡0sdr-miu.990007411360106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015000265598 ‡sMIU ‡1990007411360106381
974 ‡bMIU ‡cMIU ‡d20231224 ‡sgoogle ‡umdp.39015000265598 ‡y1980 ‡ric ‡qbib ‡tUS bib date1 >= 1929